Abstract
Genes involved in HDL structure and metabolism have been overexpressed through the introduction of transgenes or inactivated by gene targeting in mice. These new experimental substrates make it possible to address hypotheses relevant to the biology of HDL that were previously inaccessible through human studies. The in-vivo studies performed to date with these engineered mice have provided insight into structural determinants of HDL, uncovered interactions between proteins that act on HDL and clarified the role that HDL-associated proteins play in atherosclerosis. Further use of these animals, coupled with the development of new engineered lines of mice, should help unravel many questions associated with the in-vivo biological properties and metabolism of HDL.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
